GLP-1 Receptor Agonists May Lower Mortality in IMIDs and T2D

GLP-1 RAs were associated with a decreased risk for all-cause mortality and MACE in patients with immune-mediated inflammatory diseases and type 2 diabetes.
Medscape Medical News

source https://www.medscape.com/viewarticle/glp-1-receptor-agonists-may-lower-mortality-immune-mediated-2024a1000fd1?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?